THC.CN
THC Biomed Intl Ltd
Price:  
0.02 
CAD
Volume:  
16,652.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

THC.CN EV/EBITDA

-678.2%
Upside

As of 2026-01-05, the EV/EBITDA ratio of THC Biomed Intl Ltd (THC.CN) is -3.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. THC.CN's latest enterprise value is 6.24 mil CAD. THC.CN's TTM EBITDA according to its financial statements is -2.03 mil CAD. Dividing these 2 quantities gives us the above THC.CN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.4x - 8.3x 8.0x
Forward P/E multiples 5.7x - 7.1x 5.8x
Fair Price (0.19) - 0.04 (0.12)
Upside -1055.7% - 104.7% -678.2%
0.02 CAD
Stock Price
(0.12) CAD
Fair Price

THC.CN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA